Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3069-3072

  Liu, Li Teh ^a   Chang, Hui Chiu ^a   Chiang, Lien Chai ^a   Hung, Wen Chun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIMETASTATIC AGENT; CELL SURFACE PROTEIN; GELATINASE A; GLYCOPROTEIN; GLYCOPROTEIN RECK; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; RNA; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; METASTASIS INHIBITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0038408486     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sternlicht, M. D., and Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17: 463-516, 2001.
2. Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y., Noda, M. A ras-related gene with transformation suppressor activity. Cell. 56: 77-84, 1989.
3. Takahashi, C., Sheng, Z., Horan, T. P., Kitayama, H., Maki, M., Hitomi, K., Kitaura, Y., Takai, S., Sasahara, R. M. Horimoto, A., Ikawa, Y., Ratzkin, B. J., Arakawa, T., and Noda, M. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. USA, 95: 13221-13226, 1998.
4. Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., Ide, C., Horan, T. P., Arakawa, T., Yoshida, H., Nishikawa, S., Itoh, Y., Seiki, M., Itohara, S., Takahashi, C., and Noda, M. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 107: 789-800, 2001.
5. Furumoto, K., Ahi, S., Mori, A., Furuyama, H., Gorrin Rivas, M. J., Nakao, T., Isobe, N., Murata, T., Takahashi, C., Noda, M., and Imamura, M. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing-cysteine-rich protein with Kazal motifs. Hepatology, 33: 189-195, 2001.
6. Gray, G. G., and Ekstrom, T. J. The human histone deacetylase family. Exp. Cell Res., 262: 75-83, 2001.
7. Marks, P. A., Richon, V. M., Breslow, R., and Rifkind, R. A. Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol., 13: 477-483, 2001.
8. Sambucelli, L. C., Fischer, D. D., Zabludoff, S. Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H., and Cohen, D. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J. Biol. Chem., 274: 34940-34947, 1999.
9. Marks, P. A., Richon, V. M., and Rifkind, R. A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. (Bethesda), 92: 1210-1216, 2000.
10. Zhu, W. G., Lakshmanan, R. R., Beal, M. D., and Otterson, G. A. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res., 61: 1327-1333, 2001.
11. Kim, M. S., Kwon, H. J., Lee, Y. M., Baek, J. H., Jang, J. E., Lee, S. W., Moon, E. J., Kim, H. S., Lee, S. K., Chung, H. Y., Kim, C. W., and Kim, K. W. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med., 7: 437-443, 2001.
12. Gottlicher, M., Minucci, S., Zhu, P., Kramer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Lo Coco, F., Nemi, C., Pelicci, P. G., and Heinzel, T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J., 20: 6969-6978, 2001.
13. Kim, M. S., Son, M. W., Kim, W. B., In Park, Y., and Moon, A. Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett., 157: 23-30, 2000.
14. Kwon, H. J., Owa, T., Hassig, C. A., Shimada, J., and Schreiber, S. L. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc. Natl. Acad. Sci. USA, 95: 3356-3361, 1998.
15. Sasahara, R. M., Takahashi, C., and Noda, M. Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem. Biophys. Res. Commun., 264: 668-675, 1999.
16. Hung, W. C., Chang, H. C., Pan, M. R., Lee, T. H. and Chuang, L. Y. Induction of p27Kip1 as a mechanism underlying NS398-induced growth inhibition inhuman lung cancer cells. Mol. Pharmacol., 58: 1398-1403, 2000.
17. Pan, M. R., and Hung, W. C. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase 2 via suppression of the ERK/Sp1-mediated transcription. J. Biol. Chem., 277: 32775-32780, 2002.
18. Liu, L. T., Chang, H. C., Chiang, L. T., and Hung, W. C. Induction of RECK by nonsteroidal anti-inflammatory drugs in human lung cancer cells. Oncogene, 21: 8347-8350, 2002.
19. Deroanne, C. F., Bonjean, K., Servotte, S. Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J. M., Nusgens, B. V., and Castronovo, V. Histone deacetylase inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene, 21: 427-436, 2002.
20. Nervi, C., Borello, U., Fazi, F., Buffa, V., Pelicci, P. G., and Cossu, G. Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. Cancer Res,. 61: 1247-1249, 2002. Manuscript in preparation.